Wird geladen...
Neoadjuvant erlotinib and surgical resection of a stage iiia papillary adenocarcinoma of the lung with an L861Q activating EGFR mutation
The use of epidermal growth factor receptor tyrosine kinase inhibitors (egfr-tkis) is evolving, as is an understanding of predictive biomarkers for tumour response in non-small-cell lung cancer (nsclc). In this report, we describe a case of rapidly progressing, borderline-resectable, clinical stage...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Multimed Inc.
2012
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3364785/ https://ncbi.nlm.nih.gov/pubmed/22670114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.19.908 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|